Literature DB >> 26292984

Mouse Models of Hepatitis B Virus Pathogenesis.

Matteo Iannacone1, Luca G Guidotti2.   

Abstract

The host range of hepatitis B virus (HBV) is limited to humans and chimpanzees. As discussed in the literature, numerous studies in humans and chimpanzees have generated a great deal of information on the mechanisms that cause viral clearance, viral persistence, and disease pathogenesis during acute or chronic HBV infection. Relevant pathogenetic studies have also been performed in those few species representing natural hosts of hepadnaviruses that are related to HBV, such as the woodchuck hepatitis virus and the duck hepatitis virus. Further insight has been gained from multidisciplinary studies in transgenic or humanized chimeric mouse models expressing and/or replicating HBV to varying degrees. We provide here a concise summary of the available HBV mouse models as well as of the contributions of these models to our understanding of HBV pathogenesis.
Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26292984      PMCID: PMC4632861          DOI: 10.1101/cshperspect.a021477

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  56 in total

1.  Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site.

Authors:  T Heise; L G Guidotti; F V Chisari
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus.

Authors:  Matteo Iannacone; Giovanni Sitia; Iñigo Narvaiza; Zaverio M Ruggeri; Luca G Guidotti
Journal:  Clin Vaccine Immunol       Date:  2007-09-19

3.  HBV life cycle is restricted in mouse hepatocytes expressing human NTCP.

Authors:  Hanjie Li; Qiuyu Zhuang; Yuze Wang; Tianying Zhang; Jinghua Zhao; Yali Zhang; Junfang Zhang; Yi Lin; Quan Yuan; Ningshao Xia; Jiahuai Han
Journal:  Cell Mol Immunol       Date:  2014-02-10       Impact factor: 11.530

4.  Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma.

Authors:  Wing-Kin Sung; Hancheng Zheng; Shuyu Li; Ronghua Chen; Xiao Liu; Yingrui Li; Nikki P Lee; Wah H Lee; Pramila N Ariyaratne; Chandana Tennakoon; Fabianus H Mulawadi; Kwong F Wong; Angela M Liu; Ronnie T Poon; Sheung Tat Fan; Kwong L Chan; Zhuolin Gong; Yujie Hu; Zhao Lin; Guan Wang; Qinghui Zhang; Thomas D Barber; Wen-Chi Chou; Amit Aggarwal; Ke Hao; Wei Zhou; Chunsheng Zhang; James Hardwick; Carolyn Buser; Jiangchun Xu; Zhengyan Kan; Hongyue Dai; Mao Mao; Christoph Reinhard; Jun Wang; John M Luk
Journal:  Nat Genet       Date:  2012-05-27       Impact factor: 38.330

5.  Modeling the T-helper cell response in acute and chronic hepatitis B virus infection using T-cell receptor transgenic mice.

Authors:  M Chen; M Sällberg; S N Thung; J Hughes; J Jones; D R Milich
Journal:  Antiviral Res       Date:  2001-11       Impact factor: 5.970

6.  Oscillating CD8(+) T cell effector functions after antigen recognition in the liver.

Authors:  Masanori Isogawa; Yoshihiro Furuichi; Francis V Chisari
Journal:  Immunity       Date:  2005-07       Impact factor: 31.745

7.  Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.

Authors:  Y Shimizu; L G Guidotti; P Fowler; F V Chisari
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

8.  Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model.

Authors:  Karl-Dimiter Bissig; Tam T Le; Niels-Bjarne Woods; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-11       Impact factor: 11.205

9.  Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules.

Authors:  Sarah Dion; Maryline Bourgine; Ophélie Godon; Florence Levillayer; Marie-Louise Michel
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

10.  Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.

Authors:  K Kakimi; T E Lane; S Wieland; V C Asensio; I L Campbell; F V Chisari; L G Guidotti
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

View more
  7 in total

Review 1.  Animal models and the molecular biology of hepadnavirus infection.

Authors:  William S Mason
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

2.  Activity of nucleic acid polymers in rodent models of HBV infection.

Authors:  Katrin Schöneweis; Neil Motter; Pia L Roppert; Mengji Lu; Baoju Wang; Ingo Roehl; Dieter Glebe; Dongliang Yang; John D Morrey; Michael Roggendorf; Andrew Vaillant
Journal:  Antiviral Res       Date:  2017-11-08       Impact factor: 5.970

Review 3.  A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?

Authors:  Sabrina Schreiner; Michael Nassal
Journal:  Viruses       Date:  2017-05-22       Impact factor: 5.048

4.  Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection.

Authors:  Anna D Kosinska; Abdul Moeed; Nina Kallin; Julia Festag; Jinpeng Su; Katja Steiger; Marie-Louise Michel; Ulrike Protzer; Percy A Knolle
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

5.  Effector CD8+ T cell-derived interleukin-10 enhances acute liver immunopathology.

Authors:  Jessica Fioravanti; Pietro Di Lucia; Diletta Magini; Federica Moalli; Carolina Boni; Alexandre Pierre Benechet; Valeria Fumagalli; Donato Inverso; Andrea Vecchi; Amleto Fiocchi; Stefan Wieland; Robert Purcell; Carlo Ferrari; Francis V Chisari; Luca G Guidotti; Matteo Iannacone
Journal:  J Hepatol       Date:  2017-05-05       Impact factor: 25.083

Review 6.  HBV-Specific CD8+ T-Cell Tolerance in the Liver.

Authors:  Ian Baudi; Keigo Kawashima; Masanori Isogawa
Journal:  Front Immunol       Date:  2021-08-06       Impact factor: 7.561

7.  In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity.

Authors:  Katrin Manske; Annika Schneider; Chunkyu Ko; Percy A Knolle; Katja Steiger; Ulrike Protzer; Dirk Wohlleber
Journal:  Viruses       Date:  2021-11-13       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.